These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10855848)
1. General practitioners and mammographic screening uptake: influence of different modalities of general practitioner participation. Working Group. Giorgi D; Giordano L; Senore C; Merlino G; Negri R; Cancian M; Lerda M; Segnan N; Del Turco MR Tumori; 2000; 86(2):124-9. PubMed ID: 10855848 [TBL] [Abstract][Full Text] [Related]
2. Mammographic surveillance of asymptomatic breast cancer relatives in general practice: rate of re-attendance and GP- and patient-related barriers. Duijm LE; Guit GL; Zaat JO Fam Pract; 1997 Dec; 14(6):450-4. PubMed ID: 9476075 [TBL] [Abstract][Full Text] [Related]
3. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Segnan N; Senore C; Giordano L; Ponti A; Ronco G Tumori; 1998; 84(3):348-53. PubMed ID: 9678615 [TBL] [Abstract][Full Text] [Related]
4. Improving breast screening uptake: persuading initial non-attenders to attend. Turner KM; Wilson BJ; Gilbert FJ J Med Screen; 1994 Jul; 1(3):199-202. PubMed ID: 8790517 [TBL] [Abstract][Full Text] [Related]
5. Study of socio-economic characteristics, diagnosis and outcome of women participating or not participating in mammogram screening. Padoan M; Ferrante D; Pretti G; Magnani C Ann Ig; 2014; 26(6):518-26. PubMed ID: 25524076 [TBL] [Abstract][Full Text] [Related]
6. Can postal prompts from general practitioners improve the uptake of breast screening? A randomised controlled trial in one east London general practice. O'Connor AM; Griffiths CJ; Underwood MR; Eldridge S J Med Screen; 1998; 5(1):49-52. PubMed ID: 9575461 [TBL] [Abstract][Full Text] [Related]
7. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial. Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395 [TBL] [Abstract][Full Text] [Related]
8. The impact of reminder letters on attendance for breast cancer screening. Hayes C; O'Herlihy B; Hynes M; Johnson Z Ir J Med Sci; 1999; 168(1):29-32. PubMed ID: 10098340 [TBL] [Abstract][Full Text] [Related]
9. GPs' payment contracts and their referral practice. Mariñoso BG; Jelovac I J Health Econ; 2003 Jul; 22(4):617-35. PubMed ID: 12842318 [TBL] [Abstract][Full Text] [Related]
10. Do general practitioners facilitate the breast screening programme? Kee F Eur J Cancer Prev; 1992 Apr; 1(3):231-8. PubMed ID: 1467768 [TBL] [Abstract][Full Text] [Related]
11. Predictors of Mammography Uptake Among Italian Women Aged 50-69: a Cross-sectional Study. Unim B; Boggi R; Napoli M; Fulgenzi R; Landi A; La Torre G J Cancer Educ; 2020 Dec; 35(6):1089-1093. PubMed ID: 31183766 [TBL] [Abstract][Full Text] [Related]
12. Impact of invitation schemes on breast cancer screening coverage: A cohort study from Copenhagen, Denmark. Jacobsen KK; von Euler Chelpin M; Vejborg I; Lynge E J Med Screen; 2017 Mar; 24(1):20-26. PubMed ID: 27206815 [TBL] [Abstract][Full Text] [Related]
13. The impact of different communication and organizational strategies on mammography screening uptake in women aged 40-45 years. Giordano L; Stefanini V; Senore C; Frigerio A; Castagno R; Marra V; Dalmasso M; del Turco MR; Paci E; Segnan N Eur J Public Health; 2012 Jun; 22(3):413-8. PubMed ID: 21746751 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial. Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S Trials; 2012 Feb; 13():18. PubMed ID: 22348399 [TBL] [Abstract][Full Text] [Related]
15. Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial. Flanagan S; Kunkel J; Appleby V; Eldridge SE; Ismail S; Moreea S; Griffiths C; Walton R; Pitt M; Salmon A; Madurasinghe V; Barnes E; Simms E; Agarwal K; Foster GR Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):32-44. PubMed ID: 30477810 [TBL] [Abstract][Full Text] [Related]
16. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies. Van Roosbroeck S; Hoeck S; Van Hal G Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885 [TBL] [Abstract][Full Text] [Related]
17. Observational study to evaluate the impact of internet reminders for GPs on colorectal cancer screening uptake in Northern Italy in 2013. Gabrielli E; Bastiampillai AJ; Pontello M; Beghi G; Ceresa P; Pirola ME; Cereda D J Prev Med Hyg; 2016 Dec; 57(4):E211-E215. PubMed ID: 28167859 [TBL] [Abstract][Full Text] [Related]
18. Motivators for women to attend cervical screening: the influential role of GPs. O'Connor M; Murphy J; Martin C; O'Leary J; Sharp L; Fam Pract; 2014 Aug; 31(4):475-82. PubMed ID: 24927724 [TBL] [Abstract][Full Text] [Related]
19. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program. Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497 [TBL] [Abstract][Full Text] [Related]